Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM90J3J)

Drug Name
Brilaroxazine Drug Info
Synonyms
Brilaroxazine; 1239729-06-6; X8L60BA01I; UNII-X8L60BA01I; 6-(4-(4-(2,3-Dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo(b)(1,4)oxazin-3(4H)-one; RP-5063; 2H-1,4-Benzoxazin-3(4H)-one, 6-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-; 6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-2H-benzo(b)(1,4)oxazin-3(4H)-one; 6-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2h-benzo[b][1,4]oxazin-3(4h)-one; 2H-1,4-Benzoxazin-3(4H)-one, 6-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-; 6-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-4H-1,4-benzoxazin-3-one; Brilaroxazin; BRILAROXAZINE [INN]; BRILAROXAZINE [WHO-DD]; SCHEMBL3404085; CHEMBL5095172; BDBM312188; DTXSID001136921; AKOS040741455; DB09226; MS-28159; US9604944, 15b (Example 14); HY-109112; CS-0077721; 6-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-2H-1,4-benzoxazin-3(4H)-one; 2036070-48-9
Indication
Disease Entry ICD 11 Status REF
Idiopathic pulmonary fibrosis CB03.4 Phase 1 [1]
Pulmonary arterial hypertension BB01.0 Phase 1 [1]
Cross-matching ID
PubChem CID
46861612
TTD Drug ID
DM90J3J

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Serotoninnorepinephrinedopamine reuptake (SNDR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dasotraline DMLDQFV Attention deficit hyperactivity disorder 6A05.Z Approved [2]
RP5063 DMKUE8O Schizophrenia 6A20 Phase 2 [2]
OPC-64005 DMIK2AD Attention deficit hyperactivity disorder 6A05.Z Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Serotoninnorepinephrinedopamine reuptake (SNDR) TT8G3Z7 NOUNIPROTAC Agonist [1]

References

1 Clinical pipeline report, company report or official report of Reviva Pharmaceuticals
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of Otsuka Pharmaceutical.